Clinical trials for Fragile X Syndrome to begin in September

August 12th, 2011

UK regulatory approvals are now in place for the trials of the Novartis compound, AFQ056, for individuals with Fragile X syndrome. The Patrick Wild Centre is hosting these trials in the UK and will begin recruitment for both the adolescent and the adult trials in September 2011.

More information can be found on our Clinical Trials page.

Accessibility Statement | Site Map | Privacy

© Copyright The Patrick Wild Centre | All rights reserved
The University of Edinburgh is a charity registered in Scotland, No: SC005336

2017 | Website by Heehaw Digital